170 related articles for article (PubMed ID: 26005152)
1. Conjugating an anticancer drug onto thiolated hyaluronic acid by acid liable hydrazone linkage for its gelation and dual stimuli-response release.
Fu C; Li H; Li N; Miao X; Xie M; Du W; Zhang LM
Carbohydr Polym; 2015 Sep; 128():163-70. PubMed ID: 26005152
[TBL] [Abstract][Full Text] [Related]
2. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive controlled release of doxorubicin from polyelectrolyte multilayers.
Wang L; Ren KF; Wang HB; Wang Y; Ji J
Colloids Surf B Biointerfaces; 2015 Jan; 125():127-33. PubMed ID: 25461920
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
[TBL] [Abstract][Full Text] [Related]
5. Preparation of hyaluronic acid micro-hydrogel by biotin-avidin-specific bonding for doxorubicin-targeted delivery.
Cui Y; Li Y; Duan Q; Kakuchi T
Appl Biochem Biotechnol; 2013 Jan; 169(1):239-49. PubMed ID: 23179277
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin.
Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y
Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869
[TBL] [Abstract][Full Text] [Related]
7. Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics.
Lin CJ; Kuan CH; Wang LW; Wu HC; Chen Y; Chang CW; Huang RY; Wang TW
Biomaterials; 2016 Jun; 90():12-26. PubMed ID: 26974704
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells.
Hu K; Zhou H; Liu Y; Liu Z; Liu J; Tang J; Li J; Zhang J; Sheng W; Zhao Y; Wu Y; Chen C
Nanoscale; 2015 May; 7(18):8607-18. PubMed ID: 25898852
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells.
Cao X; Tao L; Wen S; Hou W; Shi X
Carbohydr Res; 2015 Mar; 405():70-7. PubMed ID: 25500334
[TBL] [Abstract][Full Text] [Related]
11. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment.
Yin Y; Fu C; Li M; Li X; Wang M; He L; Zhang LM; Peng Y
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():159-169. PubMed ID: 27287110
[TBL] [Abstract][Full Text] [Related]
12. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
[TBL] [Abstract][Full Text] [Related]
13. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery.
Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L
Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853
[TBL] [Abstract][Full Text] [Related]
14. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
15. Reduction/pH dual-sensitive PEGylated hyaluronan nanoparticles for targeted doxorubicin delivery.
Xu M; Qian J; Suo A; Wang H; Yong X; Liu X; Liu R
Carbohydr Polym; 2013 Oct; 98(1):181-8. PubMed ID: 23987334
[TBL] [Abstract][Full Text] [Related]
16. A pH-Responsive Hydrogel Based on a Tumor-Targeting Mesoporous Silica Nanocomposite for Sustained Cancer Labeling and Therapy.
Chen X; Liu Z
Macromol Rapid Commun; 2016 Sep; 37(18):1533-9. PubMed ID: 27448182
[TBL] [Abstract][Full Text] [Related]
17. Injectable and self-healing polysaccharide-based hydrogel for pH-responsive drug release.
Qian C; Zhang T; Gravesande J; Baysah C; Song X; Xing J
Int J Biol Macromol; 2019 Feb; 123():140-148. PubMed ID: 30419332
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid thiol modified injectable hydrogel: Synthesis, characterization, drug release, cellular drug uptake and anticancer activity.
Xu K; Yao H; Fan D; Zhou L; Wei S
Carbohydr Polym; 2021 Feb; 254():117286. PubMed ID: 33357859
[TBL] [Abstract][Full Text] [Related]
19. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
Pan YJ; Chen YY; Wang DR; Wei C; Guo J; Lu DR; Chu CC; Wang CC
Biomaterials; 2012 Sep; 33(27):6570-9. PubMed ID: 22704845
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D
Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]